国产欧美日韩综合精品一区二区三区,2021亚洲男人在线天堂,国产国产欧美一级,欧美日韩一区二区国产

<strike id="m8xe1"></strike>
  • <sub id="m8xe1"><ol id="m8xe1"><abbr id="m8xe1"></abbr></ol></sub>

    • <legend id="m8xe1"><u id="m8xe1"><blockquote id="m8xe1"></blockquote></u></legend>

      1. <sub id="m8xe1"><ol id="m8xe1"></ol></sub>

        Neuropsychopharmacology Reports
        收藏雜志
        • 數(shù)據庫收錄SCIE
        • 年發(fā)文量94

        Neuropsychopharmacology Reports

        期刊中文名:神經精神藥理學報告ISSN:2574-173X

        該雜志國際簡稱:Neuropsychopharmacology Reports,是由出版商Wiley-Blackwell出版的一本致力于發(fā)布--研究新成果的的專業(yè)學術期刊。主要發(fā)表刊登有創(chuàng)見的學術論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導作用的綜述與專論,促進學術發(fā)展,為廣大讀者服務。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術影響力。

        基本信息:
        期刊簡稱:Neuropsychopharmacology Reports
        是否OA:開放
        是否預警:
        Gold OA文章占比:74.37%
        出版信息:
        出版地區(qū):Australia
        出版語言:English
        出版商:Wiley-Blackwell
        評價信息:
        JCR分區(qū):Q3
        影響因子:2
        CiteScore:3.6
        雜志介紹 JCR分區(qū) CiteScore 投稿經驗

        雜志介紹

        Neuropsychopharmacology Reports雜志介紹

        《Neuropsychopharmacology Reports》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱神經精神藥理學報告,本刊主要出版、報道領域的研究動態(tài)以及在該領域取得的各方面的經驗和科研成果,介紹該領域有關本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術信息交流,提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據庫SCIE收錄,為該領域相關學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為2,最新CiteScore 指數(shù)為3.6。

        本刊近期中國學者發(fā)表的論文主要有:

        • Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders

          Author: Fukumoto, Kentaro; Kodaka, Fumitoshi; Hasegawa, Naomi; Muraoka, Hiroyuki; Hori, Hikaru; Ichihashi, Kayo; Yasuda, Yuka; Iida, Hitoshi; Ohi, Kazutaka; Ochi, Shinichiro; Ide, Kenta; Hashimoto, Naoki; Usami, Masahide; Nakamura, Toshinori; Komatsu, Hiroshi; Okada, Tsuyoshi; Nagasawa, Tatsuya; Furihata, Ryuji; Atake, Kiyokazu; Kido, Mikio; Kikuchi, Saya; Yamagata, Hirotaka; Kishimoto, Taishiro; Makinodan, Manabu; Horai, Tadasu; Takeshima, Masahiro; Kubota, Chika; Asami, Takeshi; Katsumoto, Eiichi; Hishimoto, Akitoyo; Onitsuka, Toshiaki; Matsumoto, Junya; Miura, Kenichiro; Yamada, Hisashi; Yasui-Furukori, Norio; Watanabe, Koichiro; Inada, Ken; Otsuka, Kotaro; Hashimoto, Ryota

        • Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project

          Author: Iida, Hitoshi; Okada, Tsuyoshi; Nemoto, Kiyotaka; Hasegawa, Naomi; Numata, Shusuke; Ogasawara, Kazuyoshi; Miura, Kenichiro; Matsumoto, Junya; Hori, Hikaru; Iga, Jun-ichi; Ichihashi, Kayo; Hashimoto, Naoki; Yamada, Hisashi; Ohi, Kazutaka; Yasui-Furukori, Norio; Fukumoto, Kentaro; Tsuboi, Takashi; Usami, Masahide; Furihata, Ryuji; Takaesu, Yoshikazu; Hishimoto, Akitoyo; Muraoka, Hiroyuki; Katsumoto, Eiichi; Nagasawa, Tatsuya; Ochi, Shinichiro; Komatsu, Hiroshi; Kikuchi, Saya; Takeshima, Masahiro; Onitsuka, Toshiaki; Tamai, Shinichiro; Kubota, Chika; Inada, Ken; Watanabe, Koichiro; Kawasaki, Hiroaki; Hashimoto, Ryota

        英文介紹

        Neuropsychopharmacology Reports雜志英文介紹

        Neuropsychopharmacology Reports is a peer-reviewed open access journal focused on the field of neuropsychological pharmacology. This journal aims to rapidly disseminate research findings on neurological function, psychiatry, drug mechanisms of action, and new drug development. The content of the journal covers a wide range of research from basic science to clinical trials, providing an important knowledge exchange platform for researchers, clinical doctors, and other healthcare professionals.

        The main readership of this magazine includes neuroscientists, psychiatrists, pharmacologists, clinical doctors, graduate students, and postdoctoral researchers. One of its characteristics is its fast publishing model, which helps researchers quickly share their findings and drive scientific progress in the field. In addition, the journal emphasizes the clinical relevance of research and encourages submission of studies that can directly impact patient care and treatment. Through an open access publishing model, this journal ensures wide accessibility of research findings, promotes scientific collaboration and knowledge dissemination on a global scale.

        JCR分區(qū)(2023-2024年最新版)

        Neuropsychopharmacology Reports雜志 JCR分區(qū)信息

        按JIF指標學科分區(qū)
        學科:NEUROSCIENCES
        收錄子集:ESCI
        分區(qū):Q3
        排名:228 / 310
        百分位:

        26.6%

        學科:PHARMACOLOGY & PHARMACY
        收錄子集:ESCI
        分區(qū):Q3
        排名:222 / 354
        百分位:

        37.4%

        學科:PSYCHIATRY
        收錄子集:ESCI
        分區(qū):Q3
        排名:157 / 276
        百分位:

        43.3%

        按JCI指標學科分區(qū)
        學科:NEUROSCIENCES
        收錄子集:ESCI
        分區(qū):Q4
        排名:236 / 310
        百分位:

        24.03%

        學科:PHARMACOLOGY & PHARMACY
        收錄子集:ESCI
        分區(qū):Q3
        排名:225 / 354
        百分位:

        36.58%

        學科:PSYCHIATRY
        收錄子集:ESCI
        分區(qū):Q3
        排名:176 / 276
        百分位:

        36.41%

        JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具,為唯一提供基于引文數(shù)據的統(tǒng)計信息的期刊評價資源。每年發(fā)布的JCR分區(qū),設置了254個具體學科。JCR分區(qū)根據每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個部分的。

        CiteScore 評價數(shù)據(2024年最新版)

        Neuropsychopharmacology Reports雜志CiteScore 評價數(shù)據

        • CiteScore 值:3.6
        • SJR:0.66
        • SNIP:0.646
        學科類別 分區(qū) 排名 百分位
        大類:Psychology 小類:Clinical Psychology Q2 121 / 311

        61%

        大類:Psychology 小類:Psychiatry and Mental Health Q2 274 / 567

        51%

        大類:Psychology 小類:Pharmacology (medical) Q3 142 / 272

        47%

        大類:Psychology 小類:Pharmacology Q3 188 / 313

        40%

        歷年影響因子和期刊自引率

        投稿經驗

        Neuropsychopharmacology Reports雜志投稿經驗

        該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學術影響力,行業(yè)關注度很高,已被國際權威數(shù)據庫SCIE收錄,該雜志在綜合專業(yè)領域專業(yè)度認可很高,對稿件內容的創(chuàng)新性和學術性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時間都較長,投稿過審時間平均 14 Weeks ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。

        免責聲明

        若用戶需要出版服務,請聯(lián)系出版商。